Anika Therapeutics
ANIK
136 hedge funds and large institutions have $401M invested in Anika Therapeutics in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 35 closing their positions.
53% more call options, than puts
Call options by funds: $2.69M | Put options by funds: $1.76M
33% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 42
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 159 → 136 (-23)
21% less capital invested
Capital invested by funds: $505M → $401M (-$104M)
63% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$13.1M |
| 2 |
CSC
Cove Street Capital
El Segundo,
California
|
+$11M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$4.63M |
| 4 |
LCP
Lombardia Capital Partners
Pasadena,
California
|
+$4.01M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$2.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$17M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$11.8M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$7.37M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$4.27M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$3.25M |
ANIK Hedge Fund Activity: Q2 2015 in Review
136 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q2 2015, worth a combined $401M — down 21% from $505M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of ANIK and 13 opened new positions — a net loss of 22 holders — while 42 trimmed existing stakes and 56 added.
The largest buyer was Thompson Siegel & Walmsley, adding an estimated $13.1M. The largest seller was Ranger Investment Management, exiting entirely with an estimated $17M sold.
- 136 institutional investors held Anika Therapeutics (ANIK) as of Q2 2015, down from 159 in Q1 2015.
- Funds reported $401M of Anika Therapeutics stock for Q2 2015, down 21% quarter-over-quarter.
- 13 funds opened new Anika Therapeutics positions in Q2 2015 and 35 closed out, a net change of -22 holders.
- The largest Anika Therapeutics buyer in Q2 2015 was Thompson Siegel & Walmsley, an estimated $13.1M added.
- The largest Anika Therapeutics seller in Q2 2015 was Ranger Investment Management, an estimated $17M sold.
Based on aggregated 13F filings for Q2 2015.